Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Share this:
November 10, 2013

Vedolizumab Effective for Treatment of Ulcerative Colitis & Crohn’s Disease

By Brent Westra

Note: This post was originally published on Mayo Clinic's Advancing the Science blog on August 30, 2013

Sunanda Kane, M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses two studies recently published in “The New England Journal of Medicine” (ulcerative colitis study | Crohn's disease study) that found patients with ulcerative colitis or Crohn’s disease benefited from treatment with vedolizumab compared with placebo.

Dr. Kane also discusses how the mechanism of action for vedolizumab differs from other therapies currently used to treat IBD.

For more information on IBD, visit:

Tags: medications, New England Journal of Medicine, Study Findings, Sunanda Kane

Please login or register to post a reply.
Contact Us · Privacy Policy